The Drug Delivery to the Lungs conference has terminated Vectura’s sponsorship.Read More
The scheme aims to draw more than a million qualified people. Read More
The European vapor advocate is protesting a planned increase of vapor taxes in Italy. Read More
Insights from consumers on the Pulze device will help inform the potential for further launches. Read More
The company is responding to concerns about high levels of nitrosamines. Read More
The rejections include products from prominent players such as Turning Point and Avail. Read More
The presentations focus on the Office of Small Business Assistance and warning letters. Read More
The company says it will continue its dialogue with the agency.Read More
The product offers ‘a bold burst of flavor’ and ‘a refreshing kick’ according to V&YOU. Read More
TPSAC Members will serve for overlapping terms of up to four years. Read More
Recent Posts
- Weight-Loss Drugs Suppress Tobacco Cravings
- UKVIA Updates Suppliers on Changing U.K. Landscape
- Altria Reaffirms Guidance
- U.K. Misleading Public About Relative Risk: Gilchrist
- Former Researcher Sues KT&G Over E-cigarette Patents
- Diluted Diligence
- Sampoerna Profit Jumps by One Third
- EU Urged to Adopt Science-Based Strategy
- Social Media Linked to Youth Tobacco Use
- Kenya to Consult on New Health Warnings
- New President at PMFCT
- Civil Money Penalties for 22 Elfbar Sellers
- Brazil Agency Upholds Vaping Sales Ban
- Royal College Releases New E-cig Report
- NCLA Weighs in on Cigar Rules Litigation